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ABSTRACT
Zingiber zerumbet is a plant that is traditionally consumed in many countries, including Malaysia due to its therapeutic 
properties. Previously it has been proven to inhibit migration and proliferation of cancer cells. However, its effects on normal 
cells are still unknown and would be the main focus of this study. The cytotoxicity along with proliferation and migration 
activities were evaluated against human dermal fibroblast adult cell line (HDF-a) using MTT [3-(4,5-dimethylthiazol-2-
yl)-2,5-diphenyltetrazolium], proliferation and scratch assays. The cytotoxicity effect was determined following 24 h of 
treatment by ethyl acetate Z. zerumbet extracts while proliferation assay was conducted at different concentrations (500, 
750, 1000, 1250 and 1500 μg/mL) at 24, 48 and 72 h. The cell migration rate was determined by scratch assay in 6-well 
culture plate using 10 μL pipette tip following 80% confluency at optimum concentration (750 μg/mL) of Z. zerumbet at 
different time points. Migration rate was scored at every 24 h using digital camera connected to the inverted microscope. 
The results from cytotoxicity test showed no IC
50
 values were observed for Z. zerumbet extract as compared to the positive 
control (menadione). Proliferation assay exhibited highest cell viability (137%) at 750 μg/mL. The rate of cell migration 
increased following treatment with Z. zerumbet extract after 48 h. However, the result was not significantly different 
when compared to the control. In conclusion, Z. zerumbet ethyl acetate extract is able to induce cell proliferation and 
potentially promoting migration rate of wound healing in in-vitro model.
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ABSTRAK
Zingiber zerumbet merupakan  tumbuhan ubatan tradisi yang digunakan di kebanyakan negara termasuk Malaysia 
disebabkan kesan teraputiknya. Kajian terdahulu telah membuktikan ia dapat menghalang migrasi dan proliferasi sel 
kanser. Namun, kesan pada sel normal masih belum diketahui dan menjadi fokus kajian ini. Kesan kesitotoksikan serta 
aktiviti proliferasi dan migrasi terhadap sel dewasa derma fibroblas manusia (HDF-a) dikaji menggunakan asai MTT 
[3-(4,5-dimetiltiazol-2-il)-2,5-difeniltetrazolium], proliferasi dan calaran. Kesan kesitotoksikan ditentukan selepas 
rawatan selama 24 jam ekstrak etil asetat Z. zerumbet dan asai proliferasi ditentukan pada kepekatan berbeza (500, 
750, 1000, 1250 dan 1500 μg/mL) pada 24, 48 dan 72 jam. Kadar migrasi sel ditentukan dengan asai calaran pada 
jangka waktu berbeza dalam piring kultur 6 telaga menggunakan hujung tip pipet 10 μL selepas sel mencapai 80% 
konfluensi pada kepekatan optimum (750 μg/mL) Z. zerumbet. Kadar migrasi sel ditentukan setiap 24 jam menggunakan 
kamera digital yang disambung pada mikroskop. Keputusan daripada ujian kesitotoksikan menunjukkan tiada nilai 
IC50 diperhatikan pada ekstrak Z. zerumbet apabila dibandingkan dengan kawalan positif (menadion). Asai proliferasi 
menunjukkan keviabelan sel yang tinggi (137%) pada kepekatan 750 μg/mL. Kadar migrasi sel meningkat selepas 
48 jam rawatan dengan ekstrak Z. zerumbet. Namun, keputusan menunjukkan tiada perbezaan signifikan apabila 
dibandingkan dengan kawalan. Kesimpulannya, ekstrak etil asetat Z. zerumbet merangsang proliferasi dan kadar 
migrasi sel melalui model penyembuhan luka in vitro.
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INTRODUCTION
Non-communicable diseases are known to be the leading 
cause of death as the diseases contribute to 40 million 
mortalities globally. Diabetes has been identified as one 
of the highest contribution of death as it accounts for 1.6 
million from overall cases (WHO 2017). It is estimated that 
the cost of chronic wound healing for diabetic patients 
would increase gradually as the patients who are prone to 
develop impaired wound healing continue to grow (Wong 
et al. 2013). Thus, many strategies have been done to 
reduce the cost in response to the injury and to improve 
the quality of life for the patients, including the use of 
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traditional medicine as an alternative treatment for wound 
healing as it is cheap and has been traditionally used by 
local people (Davis & Perez 2009; Dorai 2012).
 Wound healing is a process which is initiated by 
stimulation of the injury and followed by a series of 
biological events starting from the wound closure until the 
remodelling of the wound. There are four phases involved 
in wound healing process including blood coagulation, 
inflammation, cell proliferation and remodelling. Wound 
healing process requires both migration and proliferation 
of many cell types including endothelial, keratinocytes, 
neutrophils, and fibroblasts (D’souza et al. 2011). 
Fibroblast number will be increased during proliferation 
phase to synthesize substances for extracellular matrix for 
tissue granulation and collagen to provide skin integrity 
(Robson 1997). In addition, wound healing process 
involves cytokines such as platelet-derived growth factor 
(PDGF), fibroblast-derived growth factor (FGF), epidermal 
growth factor (EGF), and transforming growth factor (TGF) 
α and β that have been found to mediate this process (Sinno 
& Prakash 2013). 
 Wound such as diabetic foot ulcers can be a major 
concern to the doctors and patients due to its significant 
implication on the quality of life of the patients. In order 
to cure the wound and reduce the risk of infection in 
minor cuts and burns, antimicrobial ointments such as 
silver sulfadiazine, silver nitrate, povidone-iodine, and 
bacitracin are applied to the wound area. Chemicals and 
antibiotics that have been used to cure the wound have 
been reported to confer a number of side effects with 
being only partially effective for wound healing. The rate 
of antibiotic resistance as anti-infection in chronic wound 
healing is increasing and thus researches are now focusing 
on natural products remedy with anti-microbe properties 
(Howell-Jones et al. 2005; Kon & Rai 2014; Tan et al. 
2013). Because of these limitations, the use of medicinal 
plants have gained interest to be developed as potential 
treatment of skin ailments because of it is affordable and 
able to minimize hypersensitive reactions (Raina et al. 
2008).
 There are numerous ginger species (Zingiberaceae 
family) that are widely used in Asia due to its unique flavour 
and medicinal properties that can be used as a treatment 
for some diseases. Zingiberaceae family is considered as 
a moderately large genus of herbs with approximately 
141 species represented by genus of Zingiber that can 
be found throughout Asia. Zingiber zerumbet (L.) Smith, 
from Zingiberaceae family is locally known to the Malay 
as ‘lempoyang,’ is a traditional herb found in many 
tropical countries, including Malaysia (Yob et al. 2011). 
Its rhizomes, leaf and pine cones have been widely used 
in traditional medicine for inflammation, antirheumatic, 
constipation, diarrhea, toothache, indigestion, fever, severe 
sprains, antispasmodic, diuretic agents and worm infection 
in children (Chien et al. 2008; Sulaiman et al. 2010; Yob 
et al. 2011). 
 Previously, Z. zerumbet has been proven to 
possess biological activities such as hepatoprotective, 
nephroprotective and could inhibit cell proliferation and 
migration in multiple types of cancer cells such as leukemia 
or thymoma cells (Abdul Hamid et al. 2012; Hamid et al. 
2018, 2017; Yan et al. 2017). Z. zerumbet active compound, 
zerumbone also has shown cytotoxic and genotoxic effects 
in murine thymoma cells (Hamid et al. 2017). However, 
its effect in normal dermal cell is still unknown and thus 
to be investigated in this study. The cytotoxicity of the 
ethyl acetate extract of Z. zerumbet is determined prior 
to proliferation and migration analyses on human dermal 
fibroblast adult cell line. Human dermal fibroblast adult 
cells (HDF-a) is used as a model to mimic the human skin 
wound focusing on the third phase of wound healing 
process which is the proliferation phase. 
MATERIALS AND METHODS
PLANT MATERIALS
Fresh rhizomes of Z. zerumbet were purchased from a 
herbal farm in Temerloh, Pahang. The rhizomes was 
authenticated and deposited at Herbarium Universiti 
Kebangsaan Malaysia, Bangi, Malaysia with voucher 
specimen no. UKMB-29952. Prior to analysis, the rhizomes 
were cleaned, chopped into small pieces and air-dried at 
room temperature for three days. The dried rhizomes were 
grounded into powder form.
PREPARATION OF ETHYL ACETATE                                     
EXTRACT OF Z. ZERUMBET
The air-dried rhizomes of Z. zerumbet were sequentially 
soaked at room temperature in n-hexane, ethyl acetate and 
methanol for 72 h to produce crude extracts of hexane, ethyl 
acetate, and methanol. All the crude extracts were stored 
at 4°C until tested. Prior to experiment, the ethyl acetate 
extract of Z. zerumbet (EAZZ) was dissolved in dimethyl 
(DMSO) and diluted in phosphate buffer saline (PBS). EAZZ 
was then dissolved in DMEM without FBS, filtered and 
sterilized through 0.22 μm filter (Sartorius, Germany) for 
experimental usage (Hamid et al. 2018). 
CELL CULTURE
Human dermal fibroblast adult cells (HDF-a) were 
purchased from Science Cell, Team Medical & Scientific 
Sdn. Bhd and cultured in humidified incubator at 37ºC with 
5% CO2. Cells were maintained in Dulbecco’s Modified 
Eagle Medium (DMEM) (Life Technologies, United States) 
supplemented with 1% Penicillin/Streptomycin (PAA 
Laboratories, Austria) in T-75 flask supplemented with 5% 
fetal bovine serum until 90% confluency before subculture.
MTT-BASED CYTOTOXICITY ASSAY AND CELL 
PROLIFERATION ASSAY
Prior to MTT assay, the number of cells was counted 
using trypan blue exclusion method. HDF-a cells were 
cultured at (5 × 104) and treated in 96-well culture plates 
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(triplicate). The cytotoxicity was assessed by MTT assay 
(Mosmann 1983). Briefly, 3-[4,5-dimethylthiazol-yl]-2,5-
diphenyltetrazoliumbromide (MTT) was dissolved in PBS 
at 5 mg/mL. MTT was added to each well (10 μL per 100 
μL medium), and the plates were incubated at 37ºC with 
5% CO
2
 for 4 h. The medium was then replaced with 100 
μL DMSO and the absorbance for each well was measured 
at 570 nm using ELISA microplate reader (Biochrom ASYS, 
United Kingdom). For cell proliferation assay (Mosmann 
1983), 5 × 105 cells were cultured in 96-well plate with 
different concentrations of EAZZ (500, 750, 1000, 1250, 
and 1500 μg/mL) of EAZZ for 24, 48 and 72 h. The range 
of concentrations were chosen based on MTT result that 
does not kill 50% of the cells. 
MIGRATION RATE ANALYSIS USING SCRATCH ASSAY
HDF-a cells were grown in 6-well plates at density of 2 
× 105/mL for 48 h and a small linear scratch was created 
along the confluent monolayer of cells by gently scraping 
the surface using a sterile pipette tips (Harishkumar 2013). 
Cells were rinsed with PBS to remove cellular debris 
before being treated with EAZZ at 750 μg/mL. The images 
were taken using digital camera (Victor Company of 
Japan Limited, Japan) that was connected to the inverted 
microscope and analyzed by using image pro-express 
software (Meyer Instruments, United States). The images 
were captured at 24, 48, 72, and 96 h of treatment. The 
distance of cell travelled from the wound edge to the 
wound area in comparison to control was calculated using 
AxioVision software (Zeiss, Germany).
STATISTICAL ANALYSIS
The data was analyzed by using Statistical Package for 
Social Sciences (SPSS) version 20.0. Each experiment was 
carried out in three independents replicate. Mean values 
were calculated and One way-ANOVA test were used to 
compare the mean for more than two groups. Statistically 
significant values were set at the level of p<0.05.
RESULTS AND DISCUSSION
The result of cytotoxic assay demonstrated no IC50 value 
recorded following the treatment with EAZZ at every 
concentration (Figure 1). At lower concentrations (0-500 
μg/mL), EAZZ did not show any cytotoxicity towards 
HDF-a cell. The percentage of HDF-a cell viability showed 
significant (p<0.05) increases from 100% to 149.03 ± 
4.97% at concentration of 500 μg/mL and 100% to 151.91 
± 6.66% at a concentration of 1000 μg/mL of EAZZ. 
However, cell viability decreased significantly at higher 
concentration of EAZZ from 100% to 53.46 ± 8.30% at 
a concentration of 2000 μg/mL. This result indicates 
that the extract could reduce the cell viability at higher 
concentration (>1000 μg/mL).
 For proliferation assay, the increase of cell viability 
was observed during 24, 48, and 72 h of treatment of 
EAZZ up to 750 μg/mL before it decreased at higher 
concentrations (1000, 1250, and 1500 μg/mL) (Figure 
2). Higher concentration of EAZZ (1250 and 1500 μg/
mL) significantly (p<0.05) inhibited cell proliferation and 
displayed cytotoxic effect on HDF-a cells at 24, 48, and 
72 h. However, there was no significant difference in cell 
proliferation between the control group (untreated) and 
cell treated with EAZZ at concentrations of 500, 750, and 
1000 μg/mL.
 The rate of cell migration increased as compared to 
the control group (Table 1 & Figure 3). At 24 h, the rate 
of cell migration for treatment was slightly slower (25.50 
± 4.40%) compared to the control group (26.45 ± 4.69%). 
For 48, 72, and 96 h, the rate of cell migration towards the 
wound area was faster in treatment groups (46.08 ± 2.89%, 
52.93 ± 2.73% and 62.27 ± 2.94%, respectively) than the 
control group (Table 1).
 Previously, the proliferation study indicated some 
inhibitory effects in the proliferation of breast cancer cells 
using EAZZ extract (Hadjikakou et al. 2009). However, the 
proliferation effect of EAZZ on normal skin focusing on 
fibroblast cell has not been conducted and thus becoming 
FIGURE 1. MTT assay of human dermal fibroblast adult (HDF-a) cells were treated with different 
concentrations of ethyl acetate extract of Zingiber zerumbet (15.6, 31.25, 62.5, 125, 250, 500, 
1000, and 2000 μg/mL) for 24 h. Each value is the mean ± SD of three independent experiments. 
Asterisks indicate values which are significantly different (p<0.05) as compared to control
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FIGURE 2. Proliferation assay of human dermal fibroblast adult cells (HDF-a) treated with ethyl 
acetate extract of Zingiber zerumbet (500, 750, 1000, 1250 and 1500 μg/mL) for 24, 48 and 72 h. 
Each value is the mean ± SD of three independent experiments. Asterisks indicate values which 
are significantly different (p<0.05) from the control
TABLE 1. The rate of cell migration of human dermal fibroblast adult cells (HDF-a) treated with ethyl acetate 
extract of Zingiber zerumbet at 24, 48, 72, and 96 h in comparison to the control groups (n=3)
Incubation 
time (h)
Rate of cell migration 
for control (%)

















the main focus of this study. MTT assay demonstrated 
no IC50 value recorded at the time of treatment of less 
than 1000 μg/mL for 24 h. This finding is consistent 
with a previous study done on traditional plant extract of 
Infectoria quercus (manjakani) which did not give any 
IC50 values on human fibroblast cells (Rahman et al. 2013). 
Based on the findings of cell viability for proliferation 
assay obtained in this study, the first IC50 value was 
achieved at >1150 μg/mL after 48 h of treatment. For 72 
h, the IC50 values were measured at concentrations >1100 
μg/mL. A compound with IC50 values greater than 25 μg/
mL is considered not to cause toxicity to the cells, IC50 
values of 10 to 25 μg/mL is categorized as less toxic, IC50 
values of 5 to 10 μg/mL is moderately toxic substance and 
IC50 that is less than 5 μg/mL is categorized as an active 
compound or very toxic to cells (How et al. 2008). 
 In this study, cell proliferation assay showed high 
viability at a concentration of 500 and 750 μg/mL at 72 
h. These results indicated that these might be the suitable 
concentrations to enhance cell proliferation of HDF-a. 
Based on the percentage of cells viability, concentration 
of 750 μg/mL was chosen for scratch assay as this 
concentration gave the highest viability. However, it 
was not significant when compared with the control. 
This may be due to the mixture of active compounds 
such as zerumbone, humulene, kaempferol, verbena and 
caryophyllene oxide that are present in EAZZ that reduce 
its property (Pari et al. 2004; Singh et al.  2014). The dose 
and time dependent information could provide the specific 
information regarding the best condition in applying the 
extract to the patient.
 The active compounds found in the EAZZ extract 
can give different effects on the cells depending on the 
content (Demma et al. 2009; Pari et al. 2004). The active 
coumpounds identified in Z. zerumbet were zerumbone, 
kaempferol and humulene with zerumbone as the highest 
content in the extract (51.57%) (Ruslay 2006; Yob et 
al. 2011). The rhizomes of Z. zerumbet possess anti-
inflammatory effect and this effect is believed to be due 
to the presence of zerumbone and kaempferol. These 
compounds were shown to facilitate wound healing by 
reducing inflammation of the wound (Chien et al. 2008). 
The anti-inflammatory effects of this extract was also 
supported by a previous finding that the extract of Z. 
zerumbet able to reduce edema in rats (Nhareet et al. 
2003). In addition, another active compound found in this 
plant namely curcumin is also known to possess wound 
healing effects in rats. Curcumin increase the production 
of collagen on the wound area and has faster effect for 
wound healing (Kulac et al. 2013). Thus, curcumin 
can reduce the healing time for wounds that happened 
during inflammatory and proliferative phase in which the 
collagen formation occurs.
 Scratch assay enables identification of fibroblasts 
and cell-matrix interactions between cells. Interaction 
between cells during the migration process can resemble 
  125
cell migration that occurs during wound healing in vivo. 
The study on scratch assay demonstrated an increase in 
cell migration rate using EAZZ extract. However, at 24 h 
post-treatment, cell migration was lower as compared 
to control group. At 48, 72 and 96 h post-treatment with 
EAZZ extract, the cells migration increased. At 24 h, the 
fibroblast are still in the process of adaptation to adjust 
to the surrounding cells containing EAZZ compounds. 
The cells depend on the mechanical condition of the 
environment by using a specific protein from the 
extracellular matrix (ECM) to adapt to a new environment 
(Rhee 2009).
 Fibroblast cells produce ECM and collagen (Lodish 
et al. 2000). Previous study using other traditional plant, 
Alocasia denudata found that the proliferation phase 
starts at day 6 as the fibroblast and epitelium cells start to 
migrate into the wound area (Latif et al. 2015). ECM also 
contains polysaccharides, water and collagen that produce 
the unique characteristics of the skin. The unique feature is 
available as a result of a combination of molecules found 
in the ECM secreted by cells which are elastin, laminin, 
collagen and proteoglycans such as hyaluronan. In this 
study, it can be deduced that EAZZ extract increases cell 
proliferation of HDF-a cells thus promoting the formation 






FIGURE 3. Representative images for In Vitro migration assay of human dermal fibroblast adult (HDF-a) cells 
treated with ethyl acetate extract of Zingiber zerumbet at 24, 48, 72 and 96 h (×40). The distance of cell 
travelled from the wound edge to the wound area was calculated using AxioVision software (Zeiss, Germany)
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of ECM and fibroblasts that produce collagen at the wound 
surface.
 The percentage of cell migration using EAZZ extract 
was higher than the control, but this increase was not 
significant. In most circumstances, the cell fibroblasts 
migrated into the wound area in response to cytokines 
and growth factors such as PDGF, TGF-ß and FGF. After 
the fibroblasts have migrated into the matrix, it will start 
to grow and synthesize collagen, elastin, proteoglycans, 
and other components consisting of granulation tissue. 
Previous study has found that growth factor TGF-ß affects 
the synthesis of ECM (Greg 2005). In addition, this extract 
is also more likely to give a better impression to other cells 
such as keratinocytes that are also present in the epidermis 
layer of the skin during the healing process. 
CONCLUSION
EAZZ extract is not toxic from the concentrations up to 1000 
μg/mL and can increase cell proliferation of HDF-a cells at 
the concentration of 750 μg/mL. EAZZ has the potential to 
be developed as an alternative agent for treating wounds 
in the future.
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